4.5 Article

Nitric oxide formation in acutely rejecting cardiac allografts correlates with GTP cyclohydrolase I activity

Journal

BIOCHEMICAL JOURNAL
Volume 391, Issue -, Pages 541-547

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/BJ20050575

Keywords

biopterin; cardiac allografts; GTP cyclohydrolase I; inducible nitric oxide synthase (iNOS); tetrahydrobiopterin; transplantation

Funding

  1. NCRR NIH HHS [RR01008] Funding Source: Medline
  2. NHLBI NIH HHS [HL-64637, HL67244, R01 HL067244, R01 HL064637] Funding Source: Medline
  3. NIAID NIH HHS [AI-41703] Funding Source: Medline

Ask authors/readers for more resources

Inducible nitric oxide synthase (iNOS) is a prominent component of the complex array of mediators in acute graft rejection. While NO production is determined by iNOS expression, BH4 (tetrahydrobiopterin), a cofactor of iNOS synthesized by GTP cyclohydrolase 1, has been considered critical in sustaining NO production. In the present study, we examined time-dependent changes in iNOS and GTP cyclohydrolase I in rat cardiac allo-grafts. The increase in iNOS protein and mRNA in allografts was similar at POD4 (post-operative day 4) and POD6. However, the peak increase in intragraft NO level at POD4 was not sustained at POD6. This disparity could not be explained by any decrease in iNOS enzyme activity measured ex vivo with optimal amounts of substrate and cofactors. Lower iNOS activity could be explained by changes in total biopterin levels in allografts at POD4 that was decreased to baseline at POD6. Changes in biopterin production correlated with lower GTP cyclohydrolase I protein levels but not by any change in GTP cyclohydrolase I mRNA. Functionally, allografts displayed bradycardia and distended diastolic and systolic dimensions at POD6 but not at POD4. Likewise, histological rejection scores were increased at POD4 but with a secondary increased stage at POD6. It is hypothesized that the dissimilar amounts of NO at early and later stages of rejection is due to uncoupling of iNOS arising from disproportionate synthesis of BH4. These findings provide insight into a potential pathway regulating NO bioactivity in graft rejection. Such knowledge may potentially assist in the design of newer strategies to prevent acute graft rejection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available